Related Experiment Videos
[Anxious-depressive state and cognitive deficit in HIV infection]
D Silvestre1, F Linard, M Desi
1U158 INSERM, Hôpital Necker-Enfants Malades, Paris.
L'Encephale
|July 1, 1995
Summary
Follow-up assessments are crucial for diagnosing cognitive impairment in HIV-infected individuals. Differentiating between psychogenic causes and HIV encephalopathy requires careful consideration of anxio-depressive status and repeated evaluations.
Area of Science:
- Neuroscience
- Psychiatry
- Infectious Diseases
Context:
- Cognitive impairment is a concern in HIV-infected individuals.
- Distinguishing between various causes of cognitive decline is challenging.
- Anxio-depressive symptoms can mimic or exacerbate cognitive deficits.
Purpose:
- To highlight the importance of longitudinal assessments in evaluating cognitive impairment in HIV.
- To differentiate between psychogenic cognitive impairment and HIV encephalopathy.
- To underscore the role of anxio-depressive status in cognitive function.
Summary:
- This study followed 18 HIV-infected subjects with cognitive impairment over 6-21 months.
- Initial assessments revealed impairment in 14 subjects.
- Follow-up evaluations differentiated between psychogenic causes (7 subjects) and potential HIV encephalopathy (7 subjects), emphasizing the need for repeated neuropsychological and psychiatric assessments.
Impact:
- Establishes the necessity of follow-up trials for accurate diagnosis of cognitive impairment in HIV.
- Provides a framework for differentiating between functional and organic causes of cognitive deficits.
- Informs clinical practice regarding the comprehensive evaluation of HIV-associated cognitive changes.